Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Change in Acquisitions & Divestments (2018 - 2024)

Historic Change in Acquisitions & Divestments for Q32 Bio (QTTB) over the last 6 years, with Q3 2024 value amounting to $10.0 million.

  • Q32 Bio's Change in Acquisitions & Divestments changed N/A to $10.0 million in Q3 2024 from the same period last year, while for Jun 2025 it was $10.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $20.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, Q32 Bio's Change in Acquisitions & Divestments is $10.0 million.
  • Q32 Bio's Change in Acquisitions & Divestments' 5-year high stood at $117.0 million during Q1 2020, with a 5-year trough of $97000.0 in Q1 2024.
  • Moreover, its 4-year median value for Change in Acquisitions & Divestments was $28.5 million (2020), whereas its average is $35.8 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 212.04% in 2020, then crashed by 5909.09% in 2022.
  • Q32 Bio's Change in Acquisitions & Divestments (Quarter) stood at $39.0 million in 2020, then increased by 12.82% to $44.0 million in 2021, then crashed by 59.09% to $18.0 million in 2022, then plummeted by 44.44% to $10.0 million in 2024.
  • Its last three reported values are $10.0 million in Q3 2024, $9.9 million for Q2 2024, and $97000.0 during Q1 2024.